Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Prepaid Assets (2016 - 2026)

Anika Therapeutics has reported Prepaid Assets over the past 17 years, most recently at $3.9 million for Q1 2026.

  • Quarterly Prepaid Assets fell 32.33% to $3.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.9 million through Mar 2026, down 32.33% year-over-year, with the annual reading at $3.4 million for FY2025, 38.11% down from the prior year.
  • Prepaid Assets was $3.9 million for Q1 2026 at Anika Therapeutics, up from $3.4 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $10.5 million in Q1 2022 and troughed at $3.4 million in Q4 2025.
  • The 5-year median for Prepaid Assets is $7.5 million (2023), against an average of $7.0 million.
  • Year-over-year, Prepaid Assets grew 15.42% in 2022 and then crashed 38.11% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $8.8 million in 2022, then fell by 15.31% to $7.5 million in 2023, then dropped by 26.51% to $5.5 million in 2024, then crashed by 38.11% to $3.4 million in 2025, then rose by 15.74% to $3.9 million in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Prepaid Assets are $3.9 million (Q1 2026), $3.4 million (Q4 2025), and $5.1 million (Q3 2025).